Prof. Mustafa Ozguroglu
5
reviews
12/12/2018
07/07/2018
19/10/2014
17/09/2014
12/09/2014
Professor Mustafa Ozguroglu is a medical oncologist from Istanbul who has worked for many years at the intersection of clinical practice and international scientific research. Today he is a professor at the Department of Internal Medicine of the Cerrahpaşa Faculty of Medicine, Istanbul University-Cerrahpaşa, and heads its Clinical Research Department.
His main clinical focus is genitourinary tumors (cancer of the prostate, bladder, and kidney) and lung cancer.
Alongside his university work, he sees patients privately at Medica Tıp Merkezi in Istanbul. According to patient reviews on Turkish portals, he is described as an attentive and empathetic specialist.
Achievements and awards
About Dr. Mustafa Ozguroglu
- Lung cancer treatment
- Prostate cancer treatment
- Bladder cancer treatment
- Kidney cancer treatment
- Stomach cancer treatment
- Breast cancer treatment
- Chemotherapy
- Targeted therapy
- Immunotherapy
- Hormonal therapy
- Treatment of genitourinary tumors
- Personalized therapy of oncological diseases
- 1982–1988 — Cerrahpaşa Faculty of Medicine, Istanbul University, medical degree.
- 1988–1993 — residency in internal medicine, Cerrahpaşa Faculty of Medicine, Istanbul University.
- 1993–1996 — fellowship in medical oncology, Cerrahpaşa Faculty of Medicine, Istanbul University.
- 1996 — present — Cerrahpaşa Faculty of Medicine, Istanbul University: medical oncologist, later associate professor and professor at the Department of Medical Oncology; head of the Clinical Research Department.
- Also runs a private practice in Istanbul; currently sees patients at Medica Medical Center.
Author and co-author of more than 400 scientific publications in international medical journals. The doctor’s works have been cited more than 35,000 times by other researchers, which speaks to the high scientific significance of his research.
Main scientific directions: oncourology, lung cancer, modern drug treatment methods for oncological diseases, immunotherapy, targeted and personalized therapy.
The professor has participated in major international Phase III clinical trials dedicated to the treatment of lung cancer, prostate cancer, urothelial cancer, kidney cancer, and breast cancer. These studies were aimed at evaluating the efficacy of modern immunotherapy, hormonal, and targeted therapy drugs in patients with advanced and metastatic forms of cancer.
Among the most well-known international projects are the PACIFIC, LATITUDE, TROPIC, BOLERO-3, ADRIATIC, AMPLITUDE, and KEYNOTE-361 trials, the results of which were published in one of the world’s most authoritative medical journals — The New England Journal of Medicine (NEJM).
He also took part in studies by the Turkish Oncology Group Kidney Cancer Consortium (TKCC), dedicated to modern approaches to the treatment of kidney tumors and other urological oncological diseases.
- American Society of Clinical Oncology (ASCO)
- European Society for Medical Oncology (ESMO)
- Turkish Society of Medical Oncology
- Turkish Oncology Group
- Turkish Society of Lung Cancer
- Turkish Society of Urologic Oncology
Medica Tıp Merkezi is a private medical diagnostic center in Istanbul, housed in the historic “Villa Tozan” building. It is an outpatient medical center focused on diagnostics and consultative specialist visits.
Among the equipment important for an oncology patient: a Siemens Vida BioMatrix 3 Tesla MRI, a Siemens Force 1152-slice CT, digital color Doppler ultrasound, digital 3D mammography (tomosynthesis), digital X-ray, bone densitometry, and PET/CT.
The center also offers cardiology services (ECG, echocardiography, Holter monitoring) and a general laboratory.
